Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug safety
Pharma
FDA revisits CAR-T boxed warning on secondary cancers: Marks
“We are in the process ... of reevaluating the need for the current labeling on these products,” Peter Marks, M.D., Ph.D., said of the warnings.
Angus Liu
Nov 1, 2024 10:30am
In 3rd bankruptcy bid, J&J sweetens talc settlement offer to $8B
Sep 23, 2024 9:33am
ESMO: GSK's Zejula, pharma&'s Rubraca-Opdivo combo disappoint
Sep 14, 2024 8:45am
Eisai, Biogen's Leqembi nabs UK nod but not reimbursement
Aug 22, 2024 9:23am
GSK gets expert testimony tossed in Florida Zantac case
Aug 16, 2024 10:15am
B. Braun and Baxter launch separate drug recalls in the US
Aug 15, 2024 7:30am
